Pyk2 in the amygdala modulates chronic stress sequelae via PSD-95-related micro-structural changes

Area of Science:

• Neuroscience
• Molecular Biology
• Psychiatry

Background:

• Major depressive disorder (MDD) is a prevalent condition characterized by mood, cognitive, and sleep disturbances.
• Stressful life events are significant risk factors for MDD, leading to cellular changes like altered dendritic spine morphology.
• Pyk2, a protein-tyrosine kinase, regulates spine structure and density and is implicated in neuronal responses to stress.

Purpose of the Study:

• To investigate the role of Pyk2 in stress-induced depressive-like symptoms and associated cellular changes.
• To determine if Pyk2 inactivation confers resilience to chronic unpredictable mild stress (CUMS).

Main Methods:

• Utilized a chronic unpredictable mild stress (CUMS) paradigm in mice.
• Generated and analyzed Pyk2 knockout (KO) mice and region-specific Pyk2 KO mice (amygdala).
• Assessed anxiety-like and anhedonia-like behaviors, dendritic spine morphology, PSD-95 clustering, and NMDA receptor changes.

Main Results:

• Pyk2 KO mice exhibited reduced anxiety-like and anhedonia-like phenotypes following CUMS exposure.
• Selective Pyk2 inactivation in the amygdala fully recapitulated these resilience-promoting effects.
• Absence of Pyk2 prevented CUMS-induced alterations in spine morphology, PSD-95 clustering, and NMDA receptors.

Conclusions:

• Pyk2 plays a crucial role in mediating stress responses and synaptic plasticity in the amygdala.
• Pyk2 contributes to stress-induced micro-structural changes, and its deficit may confer resilience to chronic stress.
• Targeting Pyk2 may offer a novel therapeutic strategy for stress-related mood disorders.